Literature DB >> 23196335

Neuroimaging characteristics in mitochondrial encephalopathies associated with the m.3243A>G MTTL1 mutation.

Henriette J Tschampa1, Horst Urbach, Susanne Greschus, Wolfram S Kunz, Cornelia Kornblum.   

Abstract

Stroke-like lesions (SLL) are common radiological findings in patients with mitochondrial encephalomyopathy with lactic acidosis and stroke-like episodes (SLE; MELAS) harboring the m.3243A>G MTTL1 mutation. Imaging patterns in the m.3243A>G mutation carriers with encephalopathies lacking SLE have not been systematically examined to date. The aim of this study was to analyze brain imaging findings in encephalopathies associated with the m.3243A>G mutation irrespective of the presence or absence of SLE. Brain MRI and cranial CT scans from 11 m.3243A>G mutation carriers with encephalopathies were analyzed by two neuroradiologists in consensus. We evaluated stroke-like lesions (SLL), deep grey matter (DGM) changes on T1- and T2-weighted MR images, calcification on CT, brain atrophy, and white matter (WM) changes. SLL were present in all patients showing the full MELAS phenotype with SLE (4/11). Seven patients did not show SLE. DGM changes with T1 hyperintensity and T2 hypointensity were a distinctive finding in most patients (7/11) and present in the majority of m.3243A>G mutation carriers lacking SLE (5/7). DGM changes were also seen in half of our MELAS patients with SLL (2/4), though less pronounced. Brain atrophy was a prominent finding in general and accentuated in the cerebellum. In contrast, WM changes were rather mild and more prevalent and pronounced in MELAS. Our data stress that the distinction between MELAS with SLE and m.3243A>G mutation carriers lacking SLE is rather artificial. In clinical practice, mitochondrial disorders associated with the m.3243A>G mutation should be taken into consideration in encephalopathies with DGM changes, even when SLE and SLL are lacking.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23196335     DOI: 10.1007/s00415-012-6763-4

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  32 in total

1.  Serial diffusion imaging in a case of mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes.

Authors:  Charalampos Tzoulis; Laurence A Bindoff
Journal:  Stroke       Date:  2008-12-18       Impact factor: 7.914

2.  A mutation in the tRNA(Leu)(UUR) gene associated with the MELAS subgroup of mitochondrial encephalomyopathies.

Authors:  Y Goto; I Nonaka; S Horai
Journal:  Nature       Date:  1990-12-13       Impact factor: 49.962

Review 3.  CT and MR in non-neonatal hypoxic-ischemic encephalopathy: radiological findings with pathophysiological correlations.

Authors:  Leonardo Guilhermino Gutierrez; Alex Rovira; Luiz Antonio Pezzi Portela; Claudia da Costa Leite; Leandro Tavares Lucato
Journal:  Neuroradiology       Date:  2010-06-29       Impact factor: 2.804

4.  Vascular involvement in mitochondrial myopathy.

Authors:  R Sakuta; I Nonaka
Journal:  Ann Neurol       Date:  1989-06       Impact factor: 10.422

5.  A new rating scale for age-related white matter changes applicable to MRI and CT.

Authors:  L O Wahlund; F Barkhof; F Fazekas; L Bronge; M Augustin; M Sjögren; A Wallin; H Ader; D Leys; L Pantoni; F Pasquier; T Erkinjuntti; P Scheltens
Journal:  Stroke       Date:  2001-06       Impact factor: 7.914

6.  Regional cerebral blood flow and cerebrovascular reactivity during chronic stage of stroke-like episodes in MELAS -- implication of neurovascular cellular mechanism.

Authors:  Takahiro Iizuka; Fumihiko Sakai; Toshimitsu Ide; Saori Miyakawa; Mayumi Sato; Shintaro Yoshii
Journal:  J Neurol Sci       Date:  2007-02-21       Impact factor: 3.181

7.  Magnetic resonance imaging shows delayed ischemic striatal neurodegeneration.

Authors:  Masayuki Fujioka; Toshiaki Taoka; Yoshiyuki Matsuo; Kenichi Mishima; Kumiko Ogoshi; Yoichi Kondo; Masakazu Tsuda; Michihiro Fujiwara; Takao Asano; Toshisuke Sakaki; Akihiro Miyasaki; Darren Park; Bo K Siesjö
Journal:  Ann Neurol       Date:  2003-12       Impact factor: 10.422

8.  Serial brain imaging analysis of stroke-like episodes in MELAS.

Authors:  Hiromichi Ito; Kenji Mori; Masafumi Harada; Masako Minato; Etsuo Naito; Mayumi Takeuchi; Yasuhiro Kuroda; Shoji Kagami
Journal:  Brain Dev       Date:  2008-03-04       Impact factor: 1.961

9.  Clinical features and heteroplasmy in blood, urine and saliva in 34 Dutch families carrying the m.3243A > G mutation.

Authors:  Paul de Laat; Saskia Koene; Lambert P W J van den Heuvel; Richard J T Rodenburg; Mirian C H Janssen; Jan A M Smeitink
Journal:  J Inherit Metab Dis       Date:  2012-03-09       Impact factor: 4.982

10.  Microangiopathy in the cerebellum of patients with mitochondrial DNA disease.

Authors:  Nichola Z Lax; Ilse S Pienaar; Amy K Reeve; Philippa D Hepplewhite; Evelyn Jaros; Robert W Taylor; Raj N Kalaria; Doug M Turnbull
Journal:  Brain       Date:  2012-05-09       Impact factor: 13.501

View more
  15 in total

1.  Cortical venous disease severity in MELAS syndrome correlates with brain lesion development.

Authors:  M T Whitehead; M Wien; B Lee; N Bass; A Gropman
Journal:  Neuroradiology       Date:  2017-06-30       Impact factor: 2.804

Review 2.  Imaging of MELAS.

Authors:  Konark Malhotra; David S Liebeskind
Journal:  Curr Pain Headache Rep       Date:  2016-09

3.  Can MR spectroscopy and muscle biopsy findings be correlated with MELAS and CPEO?

Authors:  Josef Finsterer; Sinda Zarrouk-Mahjoub
Journal:  CNS Neurosci Ther       Date:  2017-08-29       Impact factor: 5.243

4.  Clinical features of MELAS and its relation with A3243G gene point mutation.

Authors:  Jin Zhang; Junhong Guo; Wanghui Fang; Qili Jun; Kaili Shi
Journal:  Int J Clin Exp Pathol       Date:  2015-10-01

5.  Frequency of MELAS main mutation in a phenotype-targeted young ischemic stroke patient population.

Authors:  Turgut Tatlisumak; Jukka Putaala; Markus Innilä; Christian Enzinger; Tiina M Metso; Sami Curtze; Bettina von Sarnowski; Alexandre Amaral-Silva; Gerhard Jan Jungehulsing; Christian Tanislav; Vincent Thijs; Arndt Rolfs; Bo Norrving; Franz Fazekas; Anu Suomalainen; Edwin H Kolodny
Journal:  J Neurol       Date:  2015-11-14       Impact factor: 4.849

6.  Brain MRS correlates with mitochondrial dysfunction biomarkers in MELAS-associated mtDNA mutations.

Authors:  Laura L Gramegna; Stefania Evangelisti; Lidia Di Vito; Chiara La Morgia; Alessandra Maresca; Leonardo Caporali; Giulia Amore; Lia Talozzi; Claudio Bianchini; Claudia Testa; David N Manners; Irene Cortesi; Maria L Valentino; Rocco Liguori; Valerio Carelli; Caterina Tonon; Raffaele Lodi
Journal:  Ann Clin Transl Neurol       Date:  2021-05-05       Impact factor: 4.511

7.  Phenotypic heterogeneity in m.3243A>G mitochondrial disease: The role of nuclear factors.

Authors:  Sarah J Pickett; John P Grady; Yi Shiau Ng; Gráinne S Gorman; Andrew M Schaefer; Ian J Wilson; Heather J Cordell; Doug M Turnbull; Robert W Taylor; Robert McFarland
Journal:  Ann Clin Transl Neurol       Date:  2018-02-07       Impact factor: 4.511

8.  Parkinson's disease: a complex interplay of mitochondrial DNA alterations and oxidative stress.

Authors:  Sarah Ciccone; Emiliano Maiani; Giovanna Bellusci; Marc Diederich; Stefania Gonfloni
Journal:  Int J Mol Sci       Date:  2013-01-24       Impact factor: 5.923

Review 9.  Review: Central nervous system involvement in mitochondrial disease.

Authors:  N Z Lax; G S Gorman; D M Turnbull
Journal:  Neuropathol Appl Neurobiol       Date:  2016-07-07       Impact factor: 8.090

10.  Consensus-based statements for the management of mitochondrial stroke-like episodes.

Authors:  Yi Shiau Ng; Laurence A Bindoff; Gráinne S Gorman; Rita Horvath; Thomas Klopstock; Michelangelo Mancuso; Mika H Martikainen; Robert Mcfarland; Victoria Nesbitt; Robert D S Pitceathly; Andrew M Schaefer; Doug M Turnbull
Journal:  Wellcome Open Res       Date:  2019-12-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.